$200 GPU credits for yctierlist foundersClaim yours →
Adialante

Adialante

Cancer screening without barriers

Spring 2026ActiveHealthcareDiagnosticsHardwareMedical DevicesHealth & WellnessRedwood City, CA, USA
Company
http://www.adialante.com
We know how to improve cancer outcomes by 8x-10x: you catch it early. MRI is the most robust and powerful cancer-detection tool in the world, yet systems cost millions to purchase, take months to install, and require high levels of technical skill to operate. We've redesigned MRI from the ground up with new physics, algorithms, and hardware, all to bring cancer screening to the entire world. Our mobile MRI is an imaging clinic on wheels. No equipment to buy, no infrastructure needed. For a flat per-scan fee, any medical site can offer MRI cancer screening. Starting with prostate cancer. Then everything else.

Note: This is a preliminary assessment based on limited publicly available information. We did not have access to LinkedIn profiles or live product screenshots for this analysis. We will update this entry with a more thorough review soon.

Verdict

High Signal
Market Opportunity
Cancer screening is a massive, underpenetrated global market. Early detection improving outcomes 8-10x is well-documented. Starting with prostate cancer (clear ICP) and expanding to full-body MRI screening is a credible wedge into a multi-billion dollar diagnostics market. Per-scan fee model targeting any medical site removes capital barrier and is a smart GTM.
Low Signal
Founder Signal
LinkedIn data is unavailable for both Parker Jenkins (COO) and Efrain Torres (CEO), making it impossible to verify any technical credentials, prior work experience, or relevant background. For a deep-tech hardware company redesigning MRI physics and hardware from the ground up, the complete absence of verifiable founder credentials is a serious red flag.
Medium Signal
Competition
No competitor data found in research, but this space has real players: Hyperfine (portable MRI, NASDAQ-listed), Promaxo (low-field MRI for prostate), and traditional OEM giants GE/Siemens/Philips. Mobile imaging companies like InSightec and various radiology-on-wheels services also exist. The 'redesigned from ground up' claim could be differentiating if the physics actually work, but that's unverified.
Low Signal
Product
No named customers, no pricing page, no demo, no revenue metrics, no press coverage. The description is compelling in concept — mobile MRI clinic on wheels for prostate cancer screening — but there is zero visible evidence of a working product, prototype, or even beta deployments. Pure vaporware signal.
OverallC Tier

The mission and market are genuinely compelling — affordable MRI cancer screening is a real problem worth solving and the TAM is enormous. However, this application has critical blind spots: zero verifiable founder background in MRI physics, hardware engineering, or medical devices, which is catastrophic for a company claiming to redesign MRI from the ground up with 'new physics and hardware.' No press, no traction, no product evidence, and opaque LinkedIn profiles make it impossible to assess execution risk. Hyperfine already proved portable MRI is technically feasible and still struggled commercially — Adialante needs to show what makes their physics approach meaningfully different and that the founding team has the deep technical credentials to actually build it.

Active Founders

Parker Jenkins
Parker Jenkins
Founder

COO at Adialante. Making cancer screening affordable.

Efrain Torres
Efrain Torres
Founder

CEO, making MRI a mass market cancer screening tool.

Adialante
Adialante
TierC Tier
BatchSpring 2026
Team Size4
StatusActive
LocationRedwood City, CA, USA
Disagree with this rating? Let us know
YC
$200 GPU creditsClaim yours →